Idiopathic Juxtafoveal Telangiectasia (IJT), also called Idiopathic Macular Telangiectasia, is a group of disorders with varying etiologies that share the common finding of telangiectatic vessels in the juxtafoveal region of the macula. IJT is classically divided into three groups, each with clinically dis-tinct findings and differing etiologies. Type I typically occurs unilaterally, primarily affects males, and is thought to be congenital. Vision loss usually results from macular edema. The most common type, II, normally presents bilaterally, has no sex predilection, and is thought to be acquired. Vision loss occurs not from edema, but from retinal atrophy. The last type, III, is extremely rare and is usually found in association with coexisting systemic or neurological disorders. Vision loss most likely results from retinal isch-emia. This paper will describe classifications, clinical findings, etiologies, and treatment options of IJT along with patient case figures.

Problem: Sickle cell disease (SCD) is an increasingly frequent global health concern whose complications may result in decreased function and reduced quality of life. SCD is a multisystem monogenic disease resulting from a mutation that causes the abnormal ‘sickling’ of erythrocytes. Subsequent local and diffuse vaso-occlusion can cause both systemic and ocular damage. Although sickle cell retinopathy (SCR) is the most commonly evoked ocular sequelae of SCD, all vascularized ocular tissues can become ischemic and progressively damaged. The combination of retinal screening of high-risk patients and early detection of the ocular sequelae of SCD with advanced diagnostic technologies should result in timely intervention and preservation of vision. Conclusion: This review of the ocular manifestations of SCD will reinforce the critical role of optometry in the multi-disciplinary care of these growing number of patients we as a profession will encounter. CE Notification: This article is available as a COPE accredited CE course. You may take this course for 2-hour credit. Read the article and take the qualifying test to earn your credit. Click here to Enroll (https://www.crojournal.com/ocular-manifestations-of-sickle-cell-disease-a-review) Please check COPE course expiry date prior to enrollment. The COPE course test must be taken before the course expiry date.

Numerous theories have been proposed regarding the pathophysiology of central serous chorioretinopathy (CSR) with no consensus on its exact etiology. Research has led to a variety of treatment possibilities which target specific mechanisms. Multimodal imaging, including fundus auto-fluorescence (FAF), optic coherence tomography (OCT), fluorescein angiography, and indocyanine green angiography identifies vascular and structural alterations which confirm the diagnosis of CSR and effectively tailors treatment and helps maximize visual prognosis in these patients. Imaging characteristics of CSR and case examples will be explored.

De nombreuses théories ont été proposées concernant la pathophysiologie de la choriorétinopathie séreuse centrale (CRSC), sans consensus sur son étiologie exacte. La recherche a mené à diverses possibilités de traitement qui ciblent des mécanismes précis. L’imagerie multimodale, y compris l’autofluorescence du fond de l’œil (FAF), la tomographie par cohérence optique (TCO), l’angiographie fluorescéinique et l’angiographie au vert d’indocyanine, identifie les altérations vasculaires et structurelles qui peuvent confirmer le diagnostic de CRSC et adapter efficacement le traitement pour aider à maximiser le pronostic visuel chez ces patients. Les caractéristiques d’imagerie de la CRSC et des exemples de cas seront explorés.